The Royal Marsden NHS Foundation Trust at FoG London 2027

Jan 27–28, 2027 London, UK ~8.3k attendees Website

The Royal Marsden NHS Foundation Trust takes part in 2 sessions at FoG London 2027 in London, its home city. Its sessions cover how to get the most patient benefit from cancer genomics at a cost the NHS can afford. The most concrete topic is how to use circulating tumour DNA testing for minimal residual disease in colorectal cancer today.

OrganizationFoG London 2027 Attendance
NHS & hospitals
Specialist NHS cancer hospital with sites in Chelsea and Sutton, partnered with the Institute of Cancer Research.
Talk
Wed Jan 27
11:30–12:00
How Can Cancer Genomics Be Optimised To Maximise Patient Benefit Without Bankrupting The NHS?
How health economics can match cancer genomic tests to the right delivery models so patients benefit without overstretching NHS budgets.
Talk
Wed Jan 27
17:30–18:00
From Prognosis to Practice: How Should We Use ctDNA-Guided MRD Testing in Colorectal Cancer Today?
What blood tests for tumour DNA left after treatment can reliably show in colorectal cancer today, and how that differs between disease stages.

Explore the full FoG London 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in London. Leave your work email and we’ll be in touch.

Privacy

Download the full FoG London 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at The Royal Marsden NHS Foundation Trust

Tell us what you sell and we’ll find the people at The Royal Marsden NHS Foundation Trust most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by Front Line Genomics or the Festival of Genomics. Submit a correction